Pharmaceutical and Device

President-Elect Donald Trump on the Pharmaceutical Industry

Read more

Why Do People Believe Drugs Are Too Expensive?

Read more

AHR Holds Congressional Briefing Focused on Cost Growth

Read more

Tandem Price Increases: Legal or Price Fixing?

Read more

A Win for Patients: Prop 61 in California Rejected

Read more

FDA Off-Label Hearing: Day One

Read more

Open Payments Having an Adverse Effect on Physician-Rep Relationships

Read more

Representative Lieu Laser-Focused on Device Act, Olympus

Read more

Ubl Gets Personal, Lays Out Vision for Future of PhRMA

Read more

PhRMA Members Invested $58.8 Billion in R&D in 2015

Read more